Nuveen Asset Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $85.1K | Hold |
46,491
| – | – | ﹤0.01% | 3300 |
|
|
2024
Q3 | $269K | Hold |
46,491
| – | – | ﹤0.01% | 3169 |
|
|
2024
Q2 | $376K | Buy |
+46,491
| New | +$376K | ﹤0.01% | 3088 |
|
|
2023
Q2 | – | Sell |
-180,997
| Closed | -$1.78M | – | 3230 |
|
|
2023
Q1 | $1.78M | Buy |
180,997
+10,624
| +6% | +$105K | ﹤0.01% | 2377 |
|
|
2022
Q4 | $3.19M | Buy |
170,373
+73,695
| +76% | +$1.38M | ﹤0.01% | 2163 |
|
|
2022
Q3 | $2M | Buy |
96,678
+379
| +0.4% | +$7.84K | ﹤0.01% | 2404 |
|
|
2022
Q2 | $2M | Buy |
96,299
+14,167
| +17% | +$294K | ﹤0.01% | 2436 |
|
|
2022
Q1 | $3.58M | Buy |
82,132
+11,062
| +16% | +$482K | ﹤0.01% | 2242 |
|
|
2021
Q4 | $4.26M | Sell |
71,070
-7,944
| -10% | -$476K | ﹤0.01% | 2216 |
|
|
2021
Q3 | $6.79M | Sell |
79,014
-101,178
| -56% | -$8.69M | ﹤0.01% | 2051 |
|
|
2021
Q2 | $20M | Buy |
180,192
+33,053
| +22% | +$3.68M | 0.01% | 1362 |
|
|
2021
Q1 | $16.4M | Buy |
147,139
+36,749
| +33% | +$4.09M | 0.01% | 1464 |
|
|
2020
Q4 | $11.7M | Buy |
110,390
+29,862
| +37% | +$3.17M | ﹤0.01% | 1599 |
|
|
2020
Q3 | $11.2M | Sell |
80,528
-9,909
| -11% | -$1.38M | ﹤0.01% | 1451 |
|
|
2020
Q2 | $29.2M | Buy |
90,437
+44,131
| +95% | +$14.3M | 0.01% | 809 |
|
|
2020
Q1 | $4.13M | Buy |
46,306
+18,630
| +67% | +$1.66M | ﹤0.01% | 1825 |
|
|
2019
Q4 | $1.1M | Sell |
27,676
-9,077
| -25% | -$359K | ﹤0.01% | 2655 |
|
|
2019
Q3 | $904K | Sell |
36,753
-1,053
| -3% | -$25.9K | ﹤0.01% | 2740 |
|
|
2019
Q2 | $1.33M | Buy |
+37,806
| New | +$1.33M | ﹤0.01% | 2622 |
|